Skip to content

TRAW

Traws Pharma, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.55
+1.49%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-59.9%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 16, 2026Pauza Charles David · officer: Chief Science Officer VirologyA-Award97,000$0.68
Jul 15, 2026Savchuk Nikolay · director, officer: Chief Operating OfficerA-Award93,000$0.68
Jul 15, 2026CAUTREELS WERNER · directorA-Award14,150$0.68
Jul 14, 2026STOVER JACK E · directorA-Award14,150$0.68
Jul 14, 2026Leaman John Harold · directorA-Award14,150$0.68
Jul 14, 2026Clarke Trafford · directorA-Award14,150$0.68
Jul 14, 2026Shoemaker Mary Teresa · directorA-Award14,150$0.68
Jul 14, 2026Parker Charles Nolan · officer: Chief Financial OfficerA-Award90,000$0.68
Jul 14, 2026Redfield Robert · officer: Chief Medical OfficerA-Award84,000$0.68
Jul 14, 2026Dukes Iain D. · director, officer: Chief Executive OfficerA-Award274,000$0.68
Apr 28, 2026ORBIMED ADVISORS LLC · 10 percent ownerPurchase597,729$1.67
Apr 28, 2026ORBIMED ADVISORS LLC · 10 percent ownerPurchase1,793,187$1.67
Apr 8, 2026Parker Charles Nolan · officer: Chief Financial OfficerA-Award104,544$1.60
Apr 8, 2026Parker Charles Nolan · officer: Chief Financial OfficerA-Award61,571$2.33
Apr 8, 2026Parker Charles Nolan · officer: Chief Financial OfficerA-Award32,406$3.01
Apr 8, 2026Parker Charles Nolan · officer: Chief Financial OfficerA-Award15,393$0.00
Mar 10, 2026CAUTREELS WERNER · directorA-Award31,258$1.60
Mar 10, 2026Clarke Trafford · directorA-Award33,435$1.60
Mar 10, 2026Redfield Robert · officer: Chief Medical OfficerA-Award108,854$1.60
Mar 10, 2026Shoemaker Mary Teresa · directorA-Award33,435$1.60
Mar 10, 2026STOVER JACK E · directorA-Award33,435$1.60
Mar 10, 2026Savchuk Nikolay · director, officer: Chief Operating OfficerA-Award96,899$1.60
Mar 10, 2026Pauza Charles David · officer: Chief Science Officer VirologyA-Award118,367$1.60
Mar 10, 2026Dukes Iain D. · director, officer: Chief Executive OfficerA-Award231,336$1.60
Mar 10, 2026Leaman John Harold · directorA-Award33,435$1.60
Dec 16, 2025Leaman John Harold · directorA-Award16,234$2.33
Dec 16, 2025Leaman John Harold · directorA-Award4,058$0.00
Dec 16, 2025Clarke Trafford · directorA-Award24,629$2.33
Dec 16, 2025Clarke Trafford · directorA-Award6,157$0.00
Dec 16, 2025CAUTREELS WERNER · directorA-Award4,874$0.00
Institutional positioning

13F filings over the trailing two quarters

New 14Increased 2Reduced 4Sold out 29
FilerActionSharesFiled
ADAGE CAPITAL PARTNERS GP, L.L.C.Unchanged730,000May 15, 2026
IKARIAN CAPITAL, LLCUnchanged678,142May 15, 2026
ORBIMED ADVISORS LLCUnchanged605,531May 15, 2026
Squadron Capital Management LLCReduced511,714May 15, 2026
DAUNTLESS INVESTMENT GROUP, LLCNew Position416,998May 14, 2026
BOOTHBAY FUND MANAGEMENT, LLCUnchanged194,536May 15, 2026
ADAR1 CAPITAL MANAGEMENT, LLCReduced154,098May 18, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased77,103May 15, 2026
PALUMBO WEALTH MANAGEMENT LLCNew Position61,175May 12, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position55,193May 15, 2026
VANGUARD FIDUCIARY TRUST CONew Position31,804May 8, 2026
STATE STREET CORPUnchanged25,802May 15, 2026
JANE STREET GROUP, LLCNew Position21,241May 12, 2026
TWO SIGMA INVESTMENTS, LPUnchanged19,244May 15, 2026
LYNX1 CAPITAL MANAGEMENT LPNew Position15,078May 4, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 16, 2026